Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history updated: added Revision v3.3.2 and removed Revision v3.2.0.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the general government funding lapse notice from the page; the previous notice warned that information may not be up to date and directed users to cc.nih.gov and opm.gov.SummaryDifference0.3%

- Check49 days agoChange DetectedCore study content remains unchanged between screenshots; any visible differences are limited to formatting or layout rather than study details. No additions or deletions affecting the trial information were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdated operational notice and version to v3.2.0; removed two cancer-type items (Cutaneous neuroendocrine carcinoma, Small cell lung carcinoma) and prior version tag v3.1.0; added links to status pages.SummaryDifference3%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated to v3.0.2 (replacing v3.0.1) and removed the Back to Top link, indicating a release update with a small UI cleanup.SummaryDifference0.2%

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.